Carvykti (ciltacabtagene autoleucel), new gene therapy to treat adult patients with multiple myeloma
EMA has recommended a conditional marketing authorisation in the European Union…
Breyanzi (lisocabtagene maraleucel), new Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
The U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene…